Lot White Cap · 2 mg vial · Krause Analytical · reported 9 February 2026 . The bar shows where the reported result falls against Astramide’s published release criterion. The notch marks the criterion.
Within criterionAbove criterionNot on this COA
Test
Method
Criterion
Result
Result vs criterion
Status
Identity
HPLC-UV-MS
Mass spectral match to the labelled compound
Confirmed
WITHIN SPEC
Chromatographic purity
HPLC-UV/MS
at or above 98.0%
99.31 %
95at or above 98.0%100
WITHIN SPEC
Net content
HPLC-UV-MS
2.04 mg
80120
REPORTED
Values are reported per vial or bottle unless otherwise noted. Every figure here is taken from the batch Certificate of Analysis and nothing else.
Certificate of Analysis
CJC-1295 (without DAC) · Lot White Cap · 2 mg vial · Lab No. 200510
Krause Analytical · 1 page · served inline, not a screenshot
Quick reference
How to read this report
Same six keys on every Astramide product page. Only the values change.
1Lot numberMatch it to the number printed on your product label. If they differ, this report is not for your product.
2IdentityMass spectrometry confirms the molecule is the one on the label. It conforms or it does not. There is no partial result.
3Chromatographic purityThe share of the material that is the target peptide. A purity figure quoted without a method is not a purity figure.
4Net contentHow much compound is in each vial or bottle, as measured by the laboratory. A different question from purity.
5EndotoxinMeasured against a ceiling, not a floor. Sensitivity differs by laboratory, so results are not compared across labs.
6Laboratory, method, dateWho ran it, on what instrument, and when. A report with no named laboratory or no date is not a report.
Molecular profile
CJC-1295 (without DAC), in structural terms.
Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
One-letter shorthand:
Y-D-A-A-I-F-T-Q-S-Y-R-K-V-L-A-Q-L-S-A-R-K-L-L-Q-D-I-L-S-R-NH₂
A commercial peptide reference lists this sequence for CJC-1295 without DAC.
Molecular formula
C₁₅₂H₂₅₂N₄₄O₄₂
Molecular weight
Approximately 3367.9 g/mol
CAS number
863288-34-0 — COA-reported This is the CAS number reported by Krause Analytical for the actual tested CJC-1295 No DAC sample.
Structure type
Linear peptide
Primary molecular target
Growth Hormone-Releasing Hormone Receptor (GHRHR) Unlike CJC-1295 with DAC, there is no albumin-binding DAC target interaction associated with this form.
CJC-1295 without DAC is a 29-amino-acid modified GHRH-derived peptide lacking the Drug Affinity Complex present in long-acting CJC-1295. Its structure incorporates substitutions intended to improve stability relative to native GHRH while preserving activity at the growth hormone-releasing hormone receptor.PubChem reports this molecular formula for CJC-1295 without DAC. The molecular weight is consistent with commercial structural records for CJC-1295 without DAC / Modified GRF (1-29).
Research profile
Where CJC-1295 (without DAC) appears in the literature.
CJC-1295 (without DAC) is investigated primarily as a GHRH analog for experimental study of the growth hormone-releasing hormone receptor and downstream endocrine signaling.
Research areas include:
GHRH receptor signaling
Growth hormone secretion pathways
IGF-1-associated signaling
Pituitary biology
Somatotroph signaling
Endocrine pathway research
GHRH analog structure-function studies
Peptide pharmacology
Modified GRF research
Growth hormone pulse signaling
The non-DAC form is structurally related to Modified GRF (1-29), a stabilized GHRH-derived peptide designed to retain GHRH receptor activity while avoiding the albumin-binding DAC modification.
This distinction is important because much of the published human literature on CJC-1295 specifically concerns the DAC-containing long-acting form, not necessarily the non-DAC peptide. Published CJC-1295 studies therefore should not automatically be used to make pharmacokinetic claims about CJC-1295 without DAC.
These are published research systems. They do not describe approved clinical applications, and they do not establish efficacy or safety in humans.
Cited literature
Teichman SL et al., 2006. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. PMID 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/
Sackmann-Sala L et al., 2009. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Horm IGF Res. PMID 19386527. https://pubmed.ncbi.nlm.nih.gov/19386527/
Memdouh S et al., 2021. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Test Anal. PMID 34665524. https://pubmed.ncbi.nlm.nih.gov/34665524/
Evidence level
Published experimental and human research. CJC-1295 without DAC appears in the published endocrinology literature, predominantly in biochemical, cellular and animal-model studies, with a smaller body of human investigation. This describes the evidence base around the molecule and does not imply approval or established efficacy.
Handling and storage
As supplied
Lyophilized powder in a sealed vial. Held in laboratory-rated freezers from arrival to shipment.
Storage
Store per the conditions printed on the vial label. Avoid heat, moisture and repeated temperature cycling.
Handling
For qualified professionals in controlled laboratory environments, following validated laboratory procedures.
Frequently asked questions
About this compound and its batch data.
What purity did this CJC-1295 without DAC batch achieve?
This lot was analysed by Krause Analytical and returned chromatographic purity of 99.31% by HPLC with UV detection coupled to mass spectrometry. Identity was confirmed by mass spectral match. The full certificate is published on this page, and every figure shown here is taken from it.
How much CJC-1295 without DAC is in the vial?
The laboratory measured 2.04 mg against a 2 mg label claim, which is 101.9% of label. Net content is reported on a per-vial basis. Astramide publishes the measured figure rather than the label claim, whether it falls above or below.
Was this CJC-1295 without DAC batch tested for endotoxins?
No endotoxin result appears on the certificate for this batch, so the row is shown as not reported rather than as a pass. Astramide does not display a result the laboratory did not produce.
How should this material be stored for research use?
As supplied, the lyophilized powder should be held at -20°C and protected from light and moisture. Once reconstituted, store at 2-8°C and use within 14 to 30 days. Avoid repeated freeze-thaw cycles and follow the handling procedures appropriate to your laboratory.
What is the difference between research-grade and pharmaceutical-grade CJC-1295 without DAC?
These are separate classifications. Research-grade material is supplied for laboratory research use only and is not intended for human or animal consumption. Pharmaceutical-grade is an FDA classification that applies to drugs manufactured for human use. Astramide supplies research-grade material only.
Why does this certificate show no lot number?
The laboratory issued this certificate with the Batch/Lot field left blank. Astramide identifies the lot by its white vial cap, lot White Cap. The certificate can still be verified against Krause Analytical laboratory reference 200510.
Research use only
This product is intended strictly for in-vitro laboratory research conducted by qualified professionals.
It is not intended for human or animal consumption, clinical use, or therapeutic application.
The statements on this page have not been reviewed by the FDA. These research peptides are not intended
to diagnose, treat, cure, or prevent any disease. Research Use Only.
Get It Now
This product has multiple variants. The options may be chosen on the product page
Added to your cart
Your cart is empty.
Your Privacy Choices
We use analytics and advertising tools to understand how visitors find us and which campaigns work. You can turn either off. Your choice is saved in this browser.
AnalyticsGoogle Analytics, Microsoft Clarity and order source tracking. Helps us see how the site is used and fix problems.
Off (browser signal)
AdvertisingMeta and X pixels, and server-side events. Opting out also opts you out of "sharing" and targeted advertising under state privacy laws.
Off (browser signal)
Your browser is sending a Global Privacy Control signal, so analytics and advertising are off. To change this, turn off the signal in your browser settings.
Strictly necessary cookies (cart, sign-in, checkout, entry acknowledgment) always stay on. See our Privacy Policy.
Know what's in it before you order.
Every Astramide batch is tested by an independent US lab. The report goes public before the batch goes on sale, so you can check the numbers first.
Independent US lab test on every batch
Full report published before it goes on sale
Kept frozen, shipped from Austin, Texas
GLP-3RLot 2026/02 · May 8, 2026
>99.9%purity by HPLC-UV/MS
90%Minimum 98.0%100%
Identity: Confirmed by mass specEndotoxin: Below 0.5 EU/mL
Pro Series
Pro Series
